Table 1. Clinical parameters of patients in the papillary renal cell carcinoma cohort obtained from The Cancer Genome Atlas (n = 285).
| Parameter | Value | Hazard ratio | 95%CI | P value |
|---|---|---|---|---|
| Age(years) | 61(28–88) | 1.004 | 0.997–1.031 | 0.792 |
| Sex | 0.149 | |||
| Female | 76 | 1.000 | ||
| Male | 209 | 0.617 | 0.320–1.190 | |
| Pathologic stagea | 2.0E-14 | |||
| StageⅠ | 170 | 1.000 | ||
| StageⅡ | 21 | 0.958 | 0.214–4.295 | |
| StageⅢ | 50 | 4.779 | 2.260–10.108 | |
| StageⅣ | 15 | 16.112 | 6.698–38.758 | |
| Clinical stageb | ||||
| StageⅠ | 138 | 1.000 | <2.0E-16 | |
| StageⅡ | 21 | 0.570 | 0.074–4.423 | |
| StageⅢ | 29 | 6.561 | 2.891–14.892 | |
| StageⅣ | 10 | 25.639 | 9.679–67.920 | |
| Tumor typec | ||||
| Type 1 | 76 | 1.000 | 0.100 | |
| Type 2 | 84 | 2.769 | 1.013–7.571 | |
| T stage d | ||||
| T1 | 191 | 1.000 | 2.0E-08 | |
| T2 | 32 | 3.161 | 1.307–7.645 | |
| T3&T4 | 60 | 6.815 | 3.408–13.66 | |
| N stage e | 1.0E-11 | |||
| N0 | 144 | 1.000 | ||
| N1&N2 | 28 | 7.715 | 3.864–15.400 | |
| M stage f | <2.0E-16 | |||
| M0 | 206 | 1.000 | ||
| M1 | 11 | 45.660 | 15.560–134.0 |
aPathologic stage was not available in 29 case
bclinical stage was not available in 87 case
cTumor type was not available in 124 case
dT stage was not available in 2 case
eN stage was not available in 113 case
f M stage was not available in 68 case.
Age is reported as the median(range).